Healthcare Of Ontario Pension Plan Trust Fund Ironwood Pharmaceuticals Inc Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$40.7 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$8.32 - $15.45 $128,960 - $239,475	-15,500 Reduced 6.16%	236,000 $2.06 Million
Q3 2023 Nov 13, 2023	SELL	$8.25 - $11.35 $260,700 - $358,660	-31,600 Reduced 11.16%	251,500 $2.42 Million
Q2 2023 Aug 11, 2023	BUY	$10.1 - $11.6 $2.86 Million - $3.28 Million	283,000 Added 283000.0%	283,100 $3.01 Million
Q1 2023 May 12, 2023	SELL	$10.37 - $12.56 $206,362 - $249,944	-19,900 Reduced 99.5%	100 $1,000
Q4 2022 Feb 13, 2023	SELL	$9.9 - $12.43 $829,620 - $1.04 Million	-83,800 Reduced 80.73%	20,000 $247,000
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $849,732 - $1.04 Million	83,800 Added 419.0%	103,800 $1.08 Million
Q2 2022 Aug 11, 2022	SELL	$11.05 - $12.72 $1.53 Million - $1.76 Million	-138,500 Reduced 87.38%	20,000 $231,000
Q1 2022 May 12, 2022	BUY	$10.61 - $12.88 $1.68 Million - $2.04 Million	158,500 New	158,500 $1.99 Million
Q4 2021 Feb 11, 2022	SELL	$10.86 - $13.95 $437,658 - $562,185	-40,300 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$11.92 - $13.92 $480,376 - $560,976	40,300 New	40,300 $526,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$84 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$80.9 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$60.2 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$41.4 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$36.4 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account